ASK REDCHAT ANYTHING ABOUT SENTI BIOSCIENCES INC.
Senti Biosciences Inc. (NASDAQ: SNTI)
Listen to this Section
$1.00
+0.0247
(
+2.53% )
64.6K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| SENTI-301ADetailsHepatocellular carcinoma |
Phase 1 |
| SENTI-202DetailsHematologic malignancies, Acute myeloid leukemia |
Phase 1 |
Market Data
|
| Open |
$1.00 |
| Previous Close |
$0.98 |
| Volume |
64.6K |
| Market Cap |
$30.38M |
| Day Range |
$0.96 - $1.01 |
| 52 Week Range |
$0.77 - $3.88 |
| Shares Outstanding |
31.14M |
| Change % |
+2.53% |
| Net Change |
▲ 0.0247 |
| Insider Ownership |
0.00% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2022 |
| Country | United States |
| Underwriter | J.P. Morgan, more |
Insider Ownership Transactions
Total Amount Purchased:
-755,778.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-12-11 |
Buy |
2222.00 |
BAYER HEALTHCARE LLC |
| 2024-07-12 |
Sale |
-62500.00 |
Mathers Edward T |
| 2024-07-12 |
Sale |
-62500.00 |
COOPERSTONE BRENDA |
| 2024-07-12 |
Sale |
-62500.00 |
Collins James J. |
| 2024-07-12 |
Sale |
-62500.00 |
Farokhzad Omid |
| 2024-02-02 |
Sale |
-101000.00 |
KNOBELMAN DEBORAH |
| 2024-02-02 |
Sale |
-306000.00 |
Lu Timothy K |
| 2024-02-02 |
Sale |
-101000.00 |
Rajangam Kanya |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 10-q |
Quarterly Reports |
76 |
Nov 13, 2025 |
| 8-k |
8K-related |
14 |
Nov 13, 2025 |
| 8-k |
8K-related |
14 |
Aug 07, 2025 |
| 10-q |
Quarterly Reports |
78 |
Aug 07, 2025 |
| 4 |
Insider transactions |
1 |
Jul 21, 2025 |
| 3 |
Insider transactions |
4 |
Jul 21, 2025 |
| 8-k |
8K-related |
14 |
Jul 18, 2025 |
| 8-k |
8K-related |
12 |
Jun 30, 2025 |
| 4 |
Insider transactions |
1 |
Jun 27, 2025 |
| 4 |
Insider transactions |
1 |
Jun 27, 2025 |